BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20805228)

  • 1. The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone.
    Rao VA; Klein SR; Bonar SJ; Zielonka J; Mizuno N; Dickey JS; Keller PW; Joseph J; Kalyanaraman B; Shacter E
    J Biol Chem; 2010 Nov; 285(45):34447-59. PubMed ID: 20805228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-crippled MitoQ potently inhibits breast cancer and glioma cell proliferation: A negative control for verifying the antioxidant mechanism of MitoQ in cancer and other oxidative pathologies.
    Cheng G; Karoui H; Hardy M; Kalyanaraman B
    Free Radic Biol Med; 2023 Aug; 205():175-187. PubMed ID: 37321281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells.
    Lee R; Lee WY; Park HJ
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MitoQ regulates redox-related noncoding RNAs to preserve mitochondrial network integrity in pressure-overload heart failure.
    Kim S; Song J; Ernst P; Latimer MN; Ha CM; Goh KY; Ma W; Rajasekaran NS; Zhang J; Liu X; Prabhu SD; Qin G; Wende AR; Young ME; Zhou L
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H682-H695. PubMed ID: 32004065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondria-targeted antioxidant MitoQ ameliorates inorganic arsenic-induced DCs/Th1/Th2/Th17/Treg differentiation partially by activating PINK1-mediated mitophagy in murine liver.
    Li H; Guo Y; Su W; Zhang H; Wei X; Ma X; Gong S; Qu G; Zhang L; Xu H; Shen F; Jiang S; Xu D; Li J
    Ecotoxicol Environ Saf; 2024 Jun; 277():116350. PubMed ID: 38653026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling.
    Reddy NM; Kleeberger SR; Bream JH; Fallon PG; Kensler TW; Yamamoto M; Reddy SP
    Oncogene; 2008 Oct; 27(44):5821-32. PubMed ID: 18542053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of autophagy in survival response induced by 27-hydroxycholesterol in human promonocytic cells.
    Vurusaner B; Gargiulo S; Testa G; Gamba P; Leonarduzzi G; Poli G; Basaga H
    Redox Biol; 2018 Jul; 17():400-410. PubMed ID: 29879549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB1 regulates liver regeneration by antagonizing the NRF2-mediated antioxidant response.
    Sun X; Wang S; Miao X; Zeng S; Guo Y; Zhou A; Chen Y; Chen Y; Lv F; Fan Z; Wang Y; Xu Y; Li Z
    Cell Death Dis; 2023 Jun; 14(6):372. PubMed ID: 37355685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial Implications of Nrf2 Inhibitors with FN3K Inhibitor:
    Beeraka NM; Zhang J; Zhao D; Liu J; A U C; Vikram Pr H; Shivaprakash P; Bannimath N; Manogaran P; Sinelnikov MY; Bannimath G; Fan R
    Curr Pharm Des; 2023; 29(30):2408-2425. PubMed ID: 37861038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives.
    Ermakov EA; Dmitrieva EM; Parshukova DA; Kazantseva DV; Vasilieva AR; Smirnova LP
    Oxid Med Cell Longev; 2021; 2021():8881770. PubMed ID: 33552387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress.
    Gonzalez Y; Aryal B; Chehab L; Rao VA
    Oncotarget; 2014 Mar; 5(6):1526-37. PubMed ID: 24681637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
    Cheng G; Zielonka J; Dranka BP; McAllister D; Mackinnon AC; Joseph J; Kalyanaraman B
    Cancer Res; 2012 May; 72(10):2634-44. PubMed ID: 22431711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the mitochondria-targeted antioxidant mitoquinone in murine acute pancreatitis.
    Huang W; Cash N; Wen L; Szatmary P; Mukherjee R; Armstrong J; Chvanov M; Tepikin AV; Murphy MP; Sutton R; Criddle DN
    Mediators Inflamm; 2015; 2015():901780. PubMed ID: 25878403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitochondrial-targeted coenzyme q analog prevents weight gain and ameliorates hepatic dysfunction in high-fat-fed mice.
    Fink BD; Herlein JA; Guo DF; Kulkarni C; Weidemann BJ; Yu L; Grobe JL; Rahmouni K; Kerns RJ; Sivitz WI
    J Pharmacol Exp Ther; 2014 Dec; 351(3):699-708. PubMed ID: 25301169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice.
    Rehman H; Liu Q; Krishnasamy Y; Shi Z; Ramshesh VK; Haque K; Schnellmann RG; Murphy MP; Lemasters JJ; Rockey DC; Zhong Z
    Int J Physiol Pathophysiol Pharmacol; 2016; 8(1):14-27. PubMed ID: 27186319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model.
    Dare AJ; Logan A; Prime TA; Rogatti S; Goddard M; Bolton EM; Bradley JA; Pettigrew GJ; Murphy MP; Saeb-Parsy K
    J Heart Lung Transplant; 2015 Nov; 34(11):1471-80. PubMed ID: 26140808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of apoptotic markers in HEI-OC1 cells treated with gentamicin with and without the mitochondria-targeted antioxidant mitoquinone.
    Jadidian A; Antonelli PJ; Ojano-Dirain CP
    Otol Neurotol; 2015 Mar; 36(3):526-30. PubMed ID: 25076226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
    Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
    Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodology for use of mitochondria-targeted cations in the field of oxidative stress-related research.
    Vyssokikh MY; Antonenko YN; Lyamzaev KG; Rokitskaya TI; Skulachev VP
    Methods Mol Biol; 2015; 1265():149-59. PubMed ID: 25634274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.
    Bao LJ; Jaramillo MC; Zhang ZB; Zheng YX; Yao M; Zhang DD; Yi XF
    Int J Clin Exp Pathol; 2014; 7(4):1502-13. PubMed ID: 24817946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.